Investigating early chronic obstructive pulmonary disease characteristics
Heterogeneity and Disease Development of Early Chronic Obstructive Pulmonary Disease
This study looks at the early signs and differences in people with early chronic obstructive pulmonary disease (COPD) to help improve how we manage and treat the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 84 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT06096285 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on understanding the clinical characteristics and variations of early chronic obstructive pulmonary disease (COPD). It aims to explore how early COPD develops and to create a multidimensional model that can predict outcomes for patients with this condition. By analyzing data from individuals diagnosed with early stages of COPD, the study seeks to provide insights that could enhance patient management and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with early stages of COPD, including those classified as PRISm, COPD Stage 0, Pre-COPD, Young COPD, and Mild COPD.
Not a fit: Patients under 18 or over 80 years old, pregnant women, or those with active malignancies or significant mental or daily activity impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and management of early COPD, potentially enhancing patient outcomes.
How similar studies have performed: While this study addresses a specific aspect of COPD, similar observational studies have shown promise in understanding disease heterogeneity and progression.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The individuals who meet the defining criteria of PRISm, COPD Stage 0, Pre-COPD, Early COPD, Young COPD, and Mild COPD, according to the latest GOLD documents and publications. Exclusion Criteria: * Age \< 18 years or \> 80 years; * Pregnant or maternal women; * Having malignant and active tumor(s), and receiving treatment; * Undergoing a surgical operation; * Having problems with mental awareness; * Having difficulties in daily activities; * Participating in other interventional clinical trials.
Where this trial is running
Beijing, Beijing
- China-Japan Friendship Hospital — Beijing, Beijing, China (Recruiting)
Study contacts
- Principal investigator: Jieping Lei, Ph.D. — China-Japan Friendship Hospital
- Study coordinator: Jieping Lei, Ph.D.
- Email: jiepinglei@126.com
- Phone: +86 010 8420 6408
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.